Sintilimab, Pegaspargase Plus GemOx for Untreated Extranodal NK/T-Cell Lymphoma

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Sintilimab, Pegaspargase Plus GemOx for Untreated Extranodal NK/T-Cell Lymphoma	Lymphoma, Extranodal NK-T-Cell, Neoplasms by Histologic Type, T-cell non-Hodgkin lymphoma, lymphoma, neoplasm	Recruiting	Phase 2	2025-02-13		NCT06824883

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Peking Union Medical College Hospital	417

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Peking Union Medical College Hospital	Beijing	China	201

Clinical trials